Candel Therapeutics (CADL) Earnings Date & Reports
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CADL is expected to report earnings to rise 13.67% to -23 cents per share on March 26
Q4'25
Est.
$-0.24
Q3'25
Missed
by $0.03
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.50
Q4'24
Missed
by $0.10
The last earnings report on November 13 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 1.21M shares outstanding, the current market capitalization sits at 275.59M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CADL showed earnings on November 13, 2025. You can read more about the earnings report here.